Home / Press Release / Global Endotoxin Testing Market Expected To Reach US$ xx Mn By 2026

Global Endotoxin Testing Market Expected To Reach US$ xx Mn By 2026

The latest market report published by Credence Research, Inc. “Endotoxin Testing Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026” the endotoxin testing market expected to grow at a CAGR of 9.5 % during the forecast period from 2018 to 2026.

Browse the full report Endotoxin Testing Market Growth, Future Prospects, and Competitive Analysis, 2018 - 2026 at  https://www.credenceresearch.com/report/endotoxin-testing-market

Market Insights

Escalation in demand for novel therapeutic drugs and medical devices has been the major factor that has led to the growing demand for endotoxin testing globally. Endotoxins can lead to pyrogenic response and symptoms of septic shock. Bacterial endotoxin testing is an essential safety requirement in the biomedical and pharmaceutical industries. Due to technological advancement, new endotoxin testing methods such as recombinant Factor C assay and monocyte activation test have been developed and distributed commercially on a global scale. The quality control tests for endotoxin testing must fulfill with regulatory requirements imposed by the European & U.S. Pharmacopoeia and the U.S. FDA. The limulus amebocyte lysate (LAL) assay test is widely utilized for pharmaceutical and biotechnology products or devices. Presently, topmost researchers trust on the conventional LAL assay test. With comprehensive understanding of endotoxin detection, new biosensors based on endotoxin-sensing components are favorable alternatives to pursue in evolving easy-operation, low-cost, and quick-response endotoxin detection methods.

Development of endotoxin testing market is driven by growing technology assessment in biologics, usage of MAT test, Recombinant Factor C assay, and increase in manufacturing of medical devices, biotechnology instruments/systems and pharmaceutical productsInstruments segment expected to show productive growth globally. Availability of wide range of products such as mycoplasma detection & removal, PCR mycoplasma detection kit, endotoxin removal products, low endotoxin recovery (LER) products and lipopolysaccharides with top applications will gain traction globally. Additionally, preference for animal-free tests is gaining popularity; new product launches along with increasing partnerships will drive the market growth successfully during the forecast period. However, less availability of advanced kits and instruments, strict regulations for medical devices, high investment for research, and affordability issues are the key factors limiting the market growth during the forecast period.

Key Market Movements:

Contact Information
24/7 Research Support
Phone: +1-800-361-8290
sales@credenceresearch.com
Get in Touch with us
Join us on Facebook
Follow us on Twitter
Join us on LinkedIn
Add us on Google +